| identifier: | 1859283 |
| description: |
epitope description:alpha-D-Glcp-(1->3)-[alpha-D-Glcp-(1->3)-alpha-D-GalpNAc-(1->4)-alpha-D-Glcp-(1->4)]-alpha-D-GalpNAc-(1->4)-alpha-D-Manp
antigen name:polysaccharide
host organism:Homo sapiens
|
| aggregation: |
instance of dataset
|
| availability: |
available
|
| primaryPublications: |
21609839 |
| authorizations: |
registration not required
|
| accessURL: |
http://www.iedb.org/reference/1022026 |
| landingPage: |
http://www.iedb.org/assay/1859283 |
| type: |
Literature
|
| publicationVenue: |
Chem Biol
|
| dates: |
2011
|
| study type: | b cell assays |
| subject species: | Clostridium difficile BI / NAP1/ 027 |
| fullName: |
Matthias A Oberli
Marie-Lyn Hecht
Pascal Bindschä
dler
Alexander Adibekian
Thomas Adam
Peter H Seeberger
|
| method: |
ELISA
|
| name: |
A possible oligosaccharide-conjugate vaccine candidate for Clostridium difficile is antigenic and immunogenic.
|
| description: |
ELISA was performed over a Glycan microarrey. Two patients with significantly increased C. difficile toxin A/B levels and one patient with a borderline test displayed high amounts of highly specific anti-epitope IgA antibodies in their excrement. The other 3 toxin positive patients were negative for anti-epitope antibodies.
|
| name: |
iedb
|
| homePage: |
http://www.iedb.org |